Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Bhavisha Desai"'
Publikováno v:
Aging and Health Research, Vol 4, Iss 2, Pp 100188- (2024)
Accounting for approximately 70 % of dementia cases and rising globally, Alzheimer's Disease Dementia (ADD) is a formidable challenge to patients, carers and healthcare professionals worldwide. ADD has a significant impact on patient's and carers’
Externí odkaz:
https://doaj.org/article/7b1892f4b7f844af8e102e9806de175d
Autor:
Daisuke Honda, MD, PhD, Michihiro Hide, MD, PhD, Tomoo Fukuda, MD, PhD, Keisuke Koga, MD, PhD, Eishin Morita, MD, PhD, Shinichi Moriwaki, MD, Yoshihiro Sasaki, MD, PhD, Yusuke Suzuki, MD, PhD, Phil Collis, PhD, Douglas T. Johnston, DO, Dianne Tomita, MPH, Bhavisha Desai, PharmD, Isao Ohsawa, MD, PhD
Publikováno v:
World Allergy Organization Journal, Vol 17, Iss 3, Pp 100882- (2024)
Background: Berotralstat is a once-daily oral inhibitor of plasma kallikrein for the prophylaxis of hereditary angioedema (HAE) in patients ≥12 years. APeX-J aimed to evaluate the efficacy and safety of berotralstat in Japan. Methods: APeX-J was a
Externí odkaz:
https://doaj.org/article/3b4e2445fcc64daeb7ca4e24132a6cc4
Autor:
Jonny G. Peter, MB ChB, MMed, FCP (SA), PhD, Bhavisha Desai, PharmD, Dianne Tomita, MPH, Phil Collis, PhD, Marcin Stobiecki, MD, PhD
Publikováno v:
World Allergy Organization Journal, Vol 16, Iss 11, Pp 100841- (2023)
Background: Given the recent approval of oral berotralstat in several countries for hereditary angioedema (HAE) prophylaxis, transition from long-term androgens to berotralstat may occur in clinical practice. The open-label, Phase II APeX-S trial pro
Externí odkaz:
https://doaj.org/article/7c11ba56ee47471087615c15e26f3f19
Autor:
Nicholas Turner, Rosemary Greenwood, Elizabeth Coulthard, Jonathan Blackman, Bhavisha Desai, Neil Carrigan, Alfie Wearn, Saba Meky, James Selwood, Hugh Piggins
Publikováno v:
BMJ Open Respiratory Research, Vol 8, Iss Suppl 1 (2021)
Externí odkaz:
https://doaj.org/article/a6e0694a758a412fa24df4d924b39cbf
Autor:
Henriette Farkas, Marcin Stobiecki, Jonny Peter, Tamar Kinaciyan, Marcus Maurer, Emel Aygören‐Pürsün, Sorena Kiani‐Alikhan, Adrian Wu, Avner Reshef, Anette Bygum, Olivier Fain, David Hagin, Aarnoud Huissoon, Miloš Jeseňák, Karen Lindsay, Vesna Grivcheva Panovska, Urs C. Steiner, Celia Zubrinich, Jessica M. Best, Melanie Cornpropst, Daniel Dix, Sylvia M. Dobo, Heather A. Iocca, Bhavisha Desai, Sharon C. Murray, Eniko Nagy, William P. Sheridan
Publikováno v:
Clinical and Translational Allergy, Vol 11, Iss 4, Pp n/a-n/a (2021)
Abstract Background Berotralstat (BCX7353) is an oral, once‐daily inhibitor of plasma kallikrein recently approved for prevention of angioedema attacks in adults and adolescents with hereditary angioedema (HAE). The objective of this report is to s
Externí odkaz:
https://doaj.org/article/857745995f5542e9849cc3caa86d3acb
Autor:
Jonathan Blackman, Neil Carrigan, Alfie Wearn, Bhavisha Desai, Saba Meky, James Selwood, Hugh Piggins, Nicholas Turner, Rosemary Greenwood, Elizabeth Coulthard
Publikováno v:
Alzheimer's & Dementia. 18
Publikováno v:
Allergy and asthma proceedings. 43(5)
Background: Hereditary angioedema (HAE) is a rare genetic disorder characterized by recurrent, localized episodes of edema. Current treatment guidelines highlight the importance of shared decision-making (SDM) during implementation of HAE management
Autor:
Daniel Soteres, William Lumry, Markus Magerl, Remi Gagnon, Bhavisha Desai, Dianne Tomita, Douglas Johnston, Marcus Maurer
Publikováno v:
Journal of Allergy and Clinical Immunology. 151:AB139
Autor:
Emel Aygören-Pürsün, Michael Manning, Olivier Fain, Bhavisha Desai, Dianne Tomita, Douglas Johnston, H. Henry Li, Sorena Kiani-Alikhan
Publikováno v:
Journal of Allergy and Clinical Immunology. 151:AB129
Publikováno v:
Journal of Allergy and Clinical Immunology. 151:AB136